“Modification and Characterization of Some New Levofloxacin Heterocyclic Derivatives as COX-2 Enzyme Inhibitors and Evaluate Their Efficacy Pharmacokinetics by Molecular Docking and the Swiss ADME Studies” (2024) Baghdad Science Journal, 21(4), p. 1255. doi:10.21123/bsj.2023.8295.